Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nanomedicine ; 9(6): 795-805, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23434679

RESUMO

Matrigel, a mouse sarcoma-derived basement membrane protein mixture, is frequently used to facilitate human tumor xenograft growth in rodents. Despite its known effects on tumor growth and metastasis, its impact on tumor pathophysiology and preclinical evaluation of nanomedicines in tumor xenografts has not been reported previously. Herein bilateral MDA435 tumors were established orthotopically with (Mat+) or without (Mat-) co-injection of Matrigel. Tumor perfusion, morphology and nanoparticle retention were evaluated. As compared to Mat- tumors, Mat+tumors exhibited enhanced vascular perfusion and lymphatic flow, greater blood vessel and lymphatic growth within the tumor core, and more deformation and collapse of lymphatics in tumor-associated lymph nodes. These changes were accompanied by reduced nanoparticle retention in Mat+tumors. The results suggest that Matrigel is not a passive medium for tumor growth, but rather significantly alters long-term tumor architecture. These findings have significant implications for the evaluation of therapeutic nanomedicine in xenograft mouse models. FROM THE CLINICAL EDITOR: Matrigel is utilized in facilitating human tumor xenograft growth in rodents. The authors demonstrate that Matrigel is not a passive medium for tumor growth; instead it significantly alters long-term tumor architecture, with major implications in the evaluation of therapeutic nanomedicine in xenograft mouse models.


Assuntos
Adenocarcinoma/fisiopatologia , Neoplasias da Mama/fisiopatologia , Colágeno/administração & dosagem , Xenoenxertos/fisiopatologia , Laminina/administração & dosagem , Proteoglicanas/administração & dosagem , Animais , Linhagem Celular Tumoral , Colágeno/metabolismo , Combinação de Medicamentos , Feminino , Humanos , Laminina/metabolismo , Camundongos , Nanomedicina , Nanopartículas/administração & dosagem , Nanopartículas/química , Proteoglicanas/metabolismo
2.
J Cell Mol Med ; 14(3): 671-86, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19243469

RESUMO

The immunosuppressive agents cyclosporin A (CsA) and FK-506 have previously been shown to exhibit neurotrophic and neuroprotective properties in vivo. Given that significant clinical expertise exists for both drugs, they represent an attractive starting point for treatment of acute neural injuries. One putative mechanism for neuroprotection by these drugs relates to inhibition of calcineurin activity. However each drug-immunophilin complex can potentially influence additional signal transduction pathways. Furthermore, several non-immunosuppressive immunophilin ligands have been described as possessing neuroprotective properties, suggesting that neuroprotection may be separable from calcineurin inhibition. In the present study, we examined the mechanism of this neuroprotection in facial motor neurons following axotomy-induced injury. Similar to previous studies in rats, CsA and FK-506 enhanced motor neuron survival in mice following acute injury. To examine the mechanism responsible for neuroprotection by these agents, pharmacologic inhibitors of several potential alternate signalling pathways (17-(allylamino)-17-demethoxygeldanamycin, rapamycin, cypermethrin) were evaluated with respect to neuroprotection. Of these, only cypermethrin, a direct calcineurin inhibitor not previously associated with neuronal survival properties, was observed to significantly enhance motor neuron survival following injury. The results demonstrate for the first time that direct inhibition of calcineurin is neuroprotective in vivo. These data support a model in which calcineurin inhibition promotes neuronal survival, distinct from effects upon neurite outgrowth.


Assuntos
Inibidores de Calcineurina , Neurônios Motores/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Piretrinas/farmacologia , Animais , Animais Recém-Nascidos , Axotomia , Calcineurina/genética , Caspase 3/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Ciclosporina/farmacologia , Ativação Enzimática/efeitos dos fármacos , Imuno-Histoquímica , Imunossupressores/farmacologia , Inseticidas/farmacologia , Camundongos , Camundongos Endogâmicos ICR , Camundongos Endogâmicos , Camundongos Knockout , Microscopia de Fluorescência , Neurônios Motores/metabolismo , Neurônios Motores/patologia , Transdução de Sinais/efeitos dos fármacos , Tacrolimo/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...